About Avid Bioservices
Avid Bioservices is a Healthcare company based in Orange (United States) founded in 2002 by Edward Legere, and was acquired by GHO Capital Partners in November 2024. Drug substance development, analytical, and compliance services are provided. The company has 501 employees. Its chief executive, as recorded, is Nicholas Green. Its website avidbio.com draws about 12 thousand monthly visits. Avid Bioservices offers products and services including Mammalian Protein Services and Viral Vector Services. Its focus areas include Biopharma Outsourcing, CDMO, Biologics and Mammalian Cell Line. Its legal entity is Avid Bioservices, Inc. Its competitors include Bionova Scientific, Just Biotherapeutics and Gallus Biopharma; 2 of its 3 listed competitors have raised funding.
Company details
Avid Bioservices was established in 2002 in Orange, United States, operating as a contract development and manufacturing organization within the biopharmaceutical industry. CGMP manufacturing capabilities are utilized for drug substances, alongside analytical testing, stability assessments, and process validation support. Quality assurance and regulatory compliance services are also delivered, including inspection readiness, to support client operations in the sector.
- Headquarters Orange, United States
- Employees 501
- Founders Edward Legere
- Stage Acquired
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website avidbio.com
- Social LinkedIn X
- Acquired by GHO Capital Partners (Nov 2024)
- Legal Name Avid Bioservices, Inc.
- Annual Revenue$139.91 M (USD)12as on Apr 30, 2024
- Net Profit$259 K (USD)-100as on Apr 30, 2023
- EBITDA-$18.68 M (USD)-619as on Apr 30, 2024
- Latest Funding Round$1.07M (USD), Grant
Sep 2009
- InvestorsHHS
& 2 more
- Employee Count501
- Acquired byGHO Capital Partners
(Nov 2024)
Products & Services of Avid Bioservices
Avid Bioservices offers a comprehensive portfolio of products and services, including Mammalian Protein Services and Viral Vector Services.
Development and manufacturing of mammalian proteins for pharmaceuticals.
Development and manufacturing of viral vectors for gene therapy.
Funding Insights of Avid Bioservices
- Total Rounds 2
- Last Round Grant — $1.07M
- First Round $943,669
(Jul 2009)
- Investors Count 1
All 2 funding rounds of Avid Bioservices with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
3 investors in total: 3 institutional.
Investors in Avid Bioservices
Avid Bioservices has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, GHO Capital and Ampersand Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Specialist healthcare investment advisory services are provided by GHO Capital. | ghocapital.com | London, United Kingdom | ||
Ampersand Capital Partners is focused on investments in healthcare and life sciences. | ampersandcapital.com | Boston, United States | ||
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for Avid Bioservices
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Avid Bioservices
89 people are tracked at Avid Bioservices (33 in leadership, 3 in board & advisors, 53 in team); the tracked headcount is 501.
| Name | Role | Group |
|---|---|---|
Edward Legere | Founder | Leadership |
Nicholas Green | CEO & President | Leadership |
Elie Hanania | VP, Process Development, Viral Vector Technologies | Leadership |
Rami Barghout | Director Of Project Engineering | Leadership |
Richard Richieri | COO | Leadership |
Pramthesh Patel | VP Process Development | Leadership |
Michael Alston, Jr. | VP, Operations | Leadership |
Mark Ziebell | VP, General Counsel & Corporate Secretary | Leadership |
Matthew Kwietniak | Chief Commercial Officer | Leadership |
Nick Ferguson | Vice President Information Technology | Leadership |
Tatiana T. S. Mello | Director Early Stage Process Development | Leadership |
Ray Marzouk | VP, Quality | Leadership |
Haiou Yang | Director Process Development | Leadership |
Gene Yoshioka | Director Of Manufacturing | Leadership |
Sarah Malain | Director, Quality Systems (quality Assurance) | Leadership |
Sajid Syed | Director, QA Lot Disposition | Leadership |
Daniel R. Hart | CFO | Leadership |
Briana Christ | Supply Chain Director | Leadership |
Colleen Miller | Director, Enterprise Resource Planning | Leadership |
Phillip Hursey | Senior Director Business Development | Leadership |
69 more people are available in the full profile.
Complete people profiles for Avid Bioservices
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Avid Bioservices
5 dated milestones of Avid Bioservices across 22 years, from founding to its latest funding, stage changes and deals.
- Founded Avid Bioservices is founded.
- Funding First funding round of $944K.
- Funding Latest funding round, Grant, of $1.1M.
- IPO Lists on the stock exchange (IPO).
- Exit Acquired by GHO Capital Partners.
Competitors of Avid Bioservices
Avid Bioservices has 3 listed competitors in our database, 2 of them funded. They include Bionova Scientific, Just Biotherapeutics and Gallus Biopharma.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| bionovascientific.com | 2013 | Fremont, United States | $22M | 72 | Mammalian cell culture biologics are developed through contract research services. | |
| justbiotherapeutics.com | 2014 | Seattle, United States | $123.51M | 79 | Designing technologies to accelerate biotherapeutic development and to reduce manufacturing costs | |
| gallusbiopharma.com | 2010 | St. Louis, United States | Biologics CDMO specializing in mammalian cell line based manufacturing |
Detailed competitors of Avid Bioservices
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Avid Bioservices
The website of Avid Bioservices (avidbio.com) receives about 12.3K visits a month and ranks #1,697,368 among all websites worldwide, #2,290 in Biotechnology and Pharmaceuticals.
- Monthly visits12.3K
▲ 23.3% vs previous month
- Unique visitors5.4K
per month
- Global rank#1,697,368
among all websites
- Category rank#2,290
Health · Biotechnology and Pharmaceuticals
- Bounce rate26%
- Pages per visit3.7
- Average visit7 min 25 sec
- DevicesDesktop 29% · Mobile 71%
Websites whose visitors overlap most with Avid Bioservices. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| bioreliance.com | 100% | 2.1K | #7,984,772 | View details | |
bioprotein.com | bioprotein.com | 100% | – | ||
| kbibiopharma.com | 100% | 32.5K | #640,532 | View details | |
| formatech.com | 100% | View details | |||
| rd-biotech.com | 100% | 1.7K | #11,064,917 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 11 similar websites and full traffic analytics for Avid Bioservices
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 11 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Avid Bioservices (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Avid Bioservices
Complete news archive for Avid Bioservices
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Avid Bioservices
Avid Bioservices was founded in 2002 and raised its 1st funding round 7 years after it was founded.
Avid Bioservices is headquartered in Orange, United States. It is registered at Orange, California, United States.
Nicholas Green is the CEO of Avid Bioservices, as recorded in our data.
Avid Bioservices has 501 employees.
Annual revenue of Avid Bioservices is $139.91M as on Apr 30, 2024.
Avid Bioservices was established in 2002 in Orange, United States, operating as a contract development and manufacturing organization within the biopharmaceutical industry. CGMP manufacturing capabilities are utilized for drug substances, alongside analytical testing, stability assessments, and process validation support. Quality assurance and regulatory compliance services are also delivered, including inspection readiness, to support client operations in the sector.
Avid Bioservices's top competitors include Bionova Scientific, Just Biotherapeutics and Gallus Biopharma.
Avid Bioservices offers Mammalian Protein Services and Viral Vector Services.
Avid Bioservices has 3 investors. Key investors include HHS, GHO Capital, and Ampersand Capital Partners.
Avid Bioservices operates through Avid Bioservices, Inc..
Yes. Avid Bioservices was acquired by GHO Capital Partners in November 2024.